Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

COVID-19 lockdown may have led to waning immunity to gastrointestinal viruses

Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but

August 11, 2023

Excessive pregnancy weight gain linked to prolonged labor, Japanese study reveals

Researchers found that excessive weight gain during pregnancy significantly increases the risk of prolonged labor in Japanese women, emphasizing the importance of monitoring weight gain

July 8, 2024

FDA leaders kick off rare disease hub to increase cross-center collaboration

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.